DK0491443T3 - Svangerskabsforebyggende middel med kun progestogen - Google Patents

Svangerskabsforebyggende middel med kun progestogen

Info

Publication number: DK0491443T3
Authority: DK; Denmark
Prior art keywords: ketodesogestrel; desogestrel; regimen; oral contraceptive; progestogen
Prior art date: 1990-12-17

Application number

DK91203328.9T

Other languages

English (en)

Inventor

Bennink Herman Jan Ti Coelingh

Engelbert Willem Bergink

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-17

Filing date

1991-12-12

Publication date

1996-06-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0491443(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-12-12 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

1996-06-24 Application granted granted Critical

1996-06-24 Publication of DK0491443T3 publication Critical patent/DK0491443T3/da

Links

239000000583 progesterone congener Substances 0.000 title 1
RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 abstract 2
229960004976 desogestrel Drugs 0.000 abstract 2
GCKFUYQCUCGESZ-BPIQYHPVSA-N etonogestrel Chemical compound O=C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 GCKFUYQCUCGESZ-BPIQYHPVSA-N 0.000 abstract 2
229940127234 oral contraceptive Drugs 0.000 abstract 2
239000003539 oral contraceptive agent Substances 0.000 abstract 2
206010027514 Metrorrhagia Diseases 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
231100000546 inhibition of ovulation Toxicity 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
208000025661 ovarian cyst Diseases 0.000 abstract 1
230000027758 ovulation cycle Effects 0.000 abstract 1
230000002085 persistent effect Effects 0.000 abstract 1
230000000717 retained effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Medicinal Preparation (AREA)
Bakery Products And Manufacturing Methods Therefor (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

DK91203328.9T 1990-12-17 1991-12-12 Svangerskabsforebyggende middel med kun progestogen DK0491443T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP90203371		1990-12-17

Publications (1)

Publication Number	Publication Date
DK0491443T3 true DK0491443T3 (da)	1996-06-24

Family

ID=8205203

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91203328.9T DK0491443T3 (da)	1990-12-17	1991-12-12	Svangerskabsforebyggende middel med kun progestogen

Country Status (20)

Country	Link
US (1)	US5461041A (da)
EP (1)	EP0491443B1 (da)
JP (1)	JPH04290829A (da)
KR (1)	KR100221008B1 (da)
CN (1)	CN1036834C (da)
AT (1)	ATE135218T1 (da)
AU (1)	AU649082B2 (da)
CA (1)	CA2057714C (da)
DE (2)	DE19975011I2 (da)
DK (1)	DK0491443T3 (da)
ES (1)	ES2087237T3 (da)
FI (1)	FI98984C (da)
GR (1)	GR3020180T3 (da)
IE (1)	IE71202B1 (da)
LU (1)	LU90341I2 (da)
NL (1)	NL990003I2 (da)
NO (2)	NO2002013I2 (da)
NZ (1)	NZ240969A (da)
PT (1)	PT99818B (da)
ZA (1)	ZA919732B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4133680A1 (de) *	1991-10-11	1993-04-15	Metallgesellschaft Ag	Stabilisierte staerke, verwendung der stabilisierten staerke und verfahren zu ihrer herstellung
DE4227989A1 (de) *	1992-08-21	1994-06-09	Schering Ag	Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
US5395627A (en) *	1992-09-04	1995-03-07	Akzo N.V.	Pharmaceutical granulate
US6407082B1 (en) *	1996-09-13	2002-06-18	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a vitamin D compound
ZA949929B (en) *	1993-12-23	1995-08-23	Akzo Nobel Nv	Sugar-coated pharmaceutical dosage unit.
DE4405590C1 (de) *	1994-02-22	1995-07-20	Hesch Rolf Dieter Prof Dr Med	Mittel zur postmenopausalen Hormonbehandlung
DK0782449T3 (da) *	1994-09-22	2003-08-04	Akzo Nobel Nv	Fremgangsmåde til fremstilling af doseringsenheder ved vådgranulering
US6765002B2 (en)	2000-03-21	2004-07-20	Gustavo Rodriguez	Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) *	1996-09-13	2000-02-22	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en)	1996-09-13	2003-01-28	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en)	1996-09-13	2000-03-07	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a Vitamin D compound
AU4134599A (en) *	1998-04-07	1999-10-25	Akzo Nobel N.V.	Progestogen-only contraceptive kit
WO2000009136A1 (en) *	1998-08-11	2000-02-24	Akzo Nobel N.V.	Progestogen-only contraceptive kit providing good cycle control
US20010044431A1 (en) *	2000-03-21	2001-11-22	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) *	2000-03-21	2004-09-09	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) *	2000-03-21	2005-05-26	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
GB0114746D0 (en)	2001-06-16	2001-08-08	Boots Co Plc	Medicinal composition
US6574033B1 (en)	2002-02-27	2003-06-03	Iridigm Display Corporation	Microelectromechanical systems device and method for fabricating same
TW200403075A (en) *	2002-05-29	2004-03-01	Akzo Nobel Nv	Progestagenic dosage units
JP5207432B2 (ja) *	2003-04-29	2013-06-12	エム・エス・ディー・オス・ベー・フェー	アンチ溶媒凝固プロセス
DE102005053771A1 (de) *	2005-11-09	2007-05-10	Grünenthal GmbH	Darreichform zur hormonalen Kontrazeption
DE202010010589U1 (de)	2010-07-22	2010-10-14	Bayer Schering Pharma Aktiengesellschaft	Estrogenfreie Formulierung zur oralen Kontrazeption, bevorzugt verwendbar für Frauen mit bewusster/unbewusster Laktoseintoleranz oder mit bewusster laktosefreier Kontrazeption
EP2730284A1 (en) *	2012-11-12	2014-05-14	Naari AG	Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation
US10441591B2 (en)	2015-06-30	2019-10-15	Shanghai Jiao Tong University	Applications for etonogestrel in preparing anti-prostate cancer products
US11679114B2 (en)	2021-07-26	2023-06-20	Navad Life Sciences Pte	Progestogen-only oral contraception

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4066757A (en) *	1973-03-26	1978-01-03	Ortho Pharmaceutical Corporation	Oral contraceptive regimen
ES2054784T3 (es) *	1987-08-08	1994-08-16	Akzo Nv	Un metodo para la fabricacion de un implante.

1991
- 1991-12-09 IE IE427191A patent/IE71202B1/en not_active IP Right Cessation
- 1991-12-10 ZA ZA919732A patent/ZA919732B/xx unknown
- 1991-12-12 EP EP91203328A patent/EP0491443B1/en not_active Expired - Lifetime
- 1991-12-12 ES ES91203328T patent/ES2087237T3/es not_active Expired - Lifetime
- 1991-12-12 DE DE1999175011 patent/DE19975011I2/de active Active
- 1991-12-12 DE DE69117902T patent/DE69117902T2/de not_active Expired - Lifetime
- 1991-12-12 DK DK91203328.9T patent/DK0491443T3/da active
- 1991-12-12 AT AT91203328T patent/ATE135218T1/de not_active IP Right Cessation
- 1991-12-13 NZ NZ240969A patent/NZ240969A/en not_active IP Right Cessation
- 1991-12-13 AU AU89678/91A patent/AU649082B2/en not_active Expired
- 1991-12-16 NO NO2002013C patent/NO2002013I2/no unknown
- 1991-12-16 CA CA002057714A patent/CA2057714C/en not_active Expired - Lifetime
- 1991-12-16 FI FI915913A patent/FI98984C/fi active
- 1991-12-16 NO NO914970A patent/NO178686C/no not_active IP Right Cessation
- 1991-12-16 KR KR1019910023066A patent/KR100221008B1/ko not_active Expired - Lifetime
- 1991-12-16 PT PT99818A patent/PT99818B/pt not_active IP Right Cessation
- 1991-12-17 JP JP3333717A patent/JPH04290829A/ja active Pending
- 1991-12-17 CN CN91107997A patent/CN1036834C/zh not_active Expired - Lifetime
1994
- 1994-01-19 US US08/183,644 patent/US5461041A/en not_active Expired - Lifetime
1996
- 1996-06-07 GR GR960401542T patent/GR3020180T3/el unknown
1999
- 1999-01-22 NL NL990003C patent/NL990003I2/nl unknown
- 1999-01-27 LU LU90341C patent/LU90341I2/fr unknown

Also Published As

Publication number	Publication date
KR920011514A (ko)	1992-07-24
NO2002013I2 (no)	2007-02-26
AU8967891A (en)	1992-06-18
EP0491443B1 (en)	1996-03-13
PT99818A (pt)	1992-11-30
FI915913L (fi)	1992-06-18
ATE135218T1 (de)	1996-03-15
NO178686C (no)	1996-05-15
FI98984C (fi)	1997-09-25
JPH04290829A (ja)	1992-10-15
NL990003I1 (nl)	1999-04-01
DE69117902D1 (de)	1996-04-18
IE914271A1 (en)	1992-06-17
EP0491443A1 (en)	1992-06-24
LU90341I2 (fr)	1999-03-29
NL990003I2 (nl)	1999-05-03
ES2087237T3 (es)	1996-07-16
IE71202B1 (en)	1997-02-12
NZ240969A (en)	1994-04-27
DE69117902T2 (de)	1996-08-29
DE19975011I2 (de)	2005-05-04
ZA919732B (en)	1992-09-30
FI915913A0 (fi)	1991-12-16
FI98984B (fi)	1997-06-13
CN1036834C (zh)	1997-12-31
GR3020180T3 (en)	1996-09-30
CA2057714C (en)	2002-10-01
CN1062465A (zh)	1992-07-08
NO914970D0 (no)	1991-12-16
PT99818B (pt)	1999-05-31
AU649082B2 (en)	1994-05-12
KR100221008B1 (ko)	1999-09-15
CA2057714A1 (en)	1992-06-18
US5461041A (en)	1995-10-24
NO178686B (no)	1996-02-05
NO914970L (no)	1992-06-18

Publication	Publication Date	Title
FI915913A0 (fi)	1991-12-16	Ehkäisyvalmiste, joka sisältää ainoastaan progestogeenia
DK0402950T3 (da)	1993-10-25	Behandling af postmenopausale ulemper
LU90634I2 (fr)	2000-12-15	Gestodene et ethinylestradiol/minesse
EP0136011A3 (en)	1986-07-16	A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
KR960704553A (ko)	1996-10-09	적어도 하나의 프로게스토겐과 적어도 하나의 에스트로겐을 함유하는 대용요법용 제제(preparation for substitution therapy containing at least one progestogen and at least one estrogen)
ATE216241T1 (de)	2002-05-15	Sehr niedrigdosiertes orales kontrazeptiv mit weniger menstruationsblutungen und verzögerter wirkung
PT868188E (pt)	2003-11-28	Kit para a contracepcao em mamiferos femininos consistindo numa combinacao de gestagenio e estrogenio
NO921854L (no)	1992-05-18	Oral osmotisk doseringsform for fertilitetskontroll
FI971742A7 (fi)	1997-04-23	Kompetitiivisia progesteroniantagonisteja tarpeen sanelemaan raskauden ehkäisyyn naisilla
ATE91410T1 (de)	1993-07-15	Osmotische dosierungsform.
RU94040720A (ru)	1997-05-27	Экстроген (прогестин) антипрогестиновый, способ пероральной контрацепции и регулирования менструаций, фармацевтическая композиция и набор лекарственных средств
Crist	1974	Post-coital estrogen